Literature DB >> 2935540

Characterization of a 140-kD avian cell surface antigen as a fibronectin-binding molecule.

S K Akiyama, S S Yamada, K M Yamada.   

Abstract

A 140,000-D protein cell surface antigen (140k) complex has been implicated in fibronectin-mediated cell-substratum attachment. We have used three different experimental systems to evaluate the hypothesis that this 140k complex can function as a fibronectin receptor. A monoclonal antibody that binds to the 140k complex specifically inhibits the direct binding of 3H-labeled 75,000-D fibronectin cell-binding fragment (f75k) to chicken embryo fibroblasts in suspension. The 140k complex is retarded in its passage through an affinity column consisting of immobilized f75k, and this interaction is specifically inhibited by a synthetic peptide that contains the fibronectin cell-recognition signal sequence. Finally, exogenous purified 140k complex inhibits the attachment and spreading of chicken embryo fibroblasts on fibronectin-coated substrates. Thus, our results indicate that the 140k complex can bind directly to fibronectin and is likely to be a fibronectin receptor for chicken cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2935540      PMCID: PMC2114091          DOI: 10.1083/jcb.102.2.442

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  38 in total

1.  Synthetic peptides competitively inhibit both direct binding to fibroblasts and functional biological assays for the purified cell-binding domain of fibronectin.

Authors:  S K Akiyama; K M Yamada
Journal:  J Biol Chem       Date:  1985-09-05       Impact factor: 5.157

2.  The interaction of plasma fibronectin with fibroblastic cells in suspension.

Authors:  S K Akiyama; K M Yamada
Journal:  J Biol Chem       Date:  1985-04-10       Impact factor: 5.157

Review 3.  Cell surface interactions with extracellular materials.

Authors:  K M Yamada
Journal:  Annu Rev Biochem       Date:  1983       Impact factor: 23.643

4.  Selective inhibition of fibronectin-mediated cell adhesion by monoclonal antibodies to a cell-surface glycoprotein.

Authors:  P J Brown; R L Juliano
Journal:  Science       Date:  1985-06-21       Impact factor: 47.728

5.  Domain structure of the carboxyl-terminal half of human plasma fibronectin.

Authors:  M Hayashi; K M Yamada
Journal:  J Biol Chem       Date:  1983-03-10       Impact factor: 5.157

6.  Synthetic peptide with cell attachment activity of fibronectin.

Authors:  M Pierschbacher; E G Hayman; E Ruoslahti
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

7.  Immunocytochemical localization of 140 kD cell adhesion molecules in cultured chicken fibroblasts, and in chicken smooth muscle and intestinal epithelial tissues.

Authors:  W T Chen; J M Greve; D I Gottlieb; S J Singer
Journal:  J Histochem Cytochem       Date:  1985-06       Impact factor: 2.479

8.  Distribution of the cell substratum attachment (CSAT) antigen on myogenic and fibroblastic cells in culture.

Authors:  C H Damsky; K A Knudsen; D Bradley; C A Buck; A F Horwitz
Journal:  J Cell Biol       Date:  1985-05       Impact factor: 10.539

9.  Detachment of cells from culture substrate by soluble fibronectin peptides.

Authors:  E G Hayman; M D Pierschbacher; E Ruoslahti
Journal:  J Cell Biol       Date:  1985-06       Impact factor: 10.539

10.  A monoclonal antibody detaches embryonic skeletal muscle from extracellular matrices.

Authors:  N T Neff; C Lowrey; C Decker; A Tovar; C Damsky; C Buck; A F Horwitz
Journal:  J Cell Biol       Date:  1982-11       Impact factor: 10.539

View more
  62 in total

1.  Human colon carcinoma cells use multiple receptors to adhere to laminin: involvement of alpha 6 beta 4 and alpha 2 beta 1 integrins.

Authors:  M M Lotz; C A Korzelius; A M Mercurio
Journal:  Cell Regul       Date:  1990-02

2.  A collagen-binding glycoprotein on the surface of mouse fibroblasts is identified as dipeptidyl peptidase IV.

Authors:  B Bauvois
Journal:  Biochem J       Date:  1988-06-15       Impact factor: 3.857

3.  A dual laminin/collagen receptor acts in peripheral nerve regeneration.

Authors:  B Toyota; S Carbonetto; S David
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

4.  The very late antigen family of heterodimers is part of a superfamily of molecules involved in adhesion and embryogenesis.

Authors:  Y Takada; J L Strominger; M E Hemler
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

5.  Limited cleavage of cellular fibronectin by plasminogen activator purified from transformed cells.

Authors:  J P Quigley; L I Gold; R Schwimmer; L M Sullivan
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

6.  Phosphorylation of the fibronectin receptor complex in cells transformed by oncogenes that encode tyrosine kinases.

Authors:  R Hirst; A Horwitz; C Buck; L Rohrschneider
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

7.  An integral membrane protein antigen associated with the membrane attachment sites of actin microfilaments is identified as an integrin beta-chain.

Authors:  P A Maher; S J Singer
Journal:  Mol Cell Biol       Date:  1988-02       Impact factor: 4.272

8.  Wheat-germ-agglutinin and Ricinus communis-agglutinin-binding sites of BHK cells compared with each other and with 140 kDa fibronectin receptors.

Authors:  T L Tuan; F Grinnell
Journal:  Biochem J       Date:  1988-04-01       Impact factor: 3.857

9.  N-cadherin, NCAM, and integrins promote retinal neurite outgrowth on astrocytes in vitro.

Authors:  K M Neugebauer; K J Tomaselli; J Lilien; L F Reichardt
Journal:  J Cell Biol       Date:  1988-09       Impact factor: 10.539

10.  Embryonic neural retinal cell response to extracellular matrix proteins: developmental changes and effects of the cell substratum attachment antibody (CSAT).

Authors:  D E Hall; K M Neugebauer; L F Reichardt
Journal:  J Cell Biol       Date:  1987-03       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.